Cargando…

Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011187/ https://www.ncbi.nlm.nih.gov/pubmed/35432361 http://dx.doi.org/10.3389/fimmu.2022.902018

Ejemplares similares

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
por: Mimura, Yusuke, et al.
Publicado: (2022)

Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity
por: Smith, Alyson J., et al.
Publicado: (2023)

Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity
por: Peschke, Benjamin, et al.
Publicado: (2017)

Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
por: Dekkers, Gillian, et al.
Publicado: (2018)

Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation
por: Wei, Bingchuan, et al.
Publicado: (2021)

Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its FcγRIIIA binding affinity
por: Hatfield, Grayson, et al.
Publicado: (2022)

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
por: Hu, Yun, et al.
Publicado: (2022)

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2016)

Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
por: van Osch, Thijs L.J., et al.
Publicado: (2022)

ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis
por: Alves, Gustavo Ferreira, et al.
Publicado: (2022)

IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
por: Lundström, Susanna L., et al.
Publicado: (2017)

Immunoglobulin Glycosylation – An Unexploited Potential for Immunomodulatory Strategies in Farm Animals
por: Zlatina, Kristina, et al.
Publicado: (2021)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
por: Colado, Ana, et al.
Publicado: (2021)

IgG1 Fc N-glycan galactosylation as a biomarker for immune activation
por: de Jong, Sanne E., et al.
Publicado: (2016)

Intravenous Immunoglobulin and Immunomodulation of B-Cell – in vitro and in vivo Effects
por: Mitrevski, Milica, et al.
Publicado: (2015)

Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
por: Bohländer, Fabian, et al.
Publicado: (2021)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides
por: Yamada, Tsuyoshi, et al.
Publicado: (2016)

Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
por: Ha, Ji-Hee, et al.
Publicado: (2016)

Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G
por: Fokkink, Willem Jan R., et al.
Publicado: (2015)

Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide
por: Veerapen, Natacha, et al.
Publicado: (2009)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury
por: Thom, Vivien, et al.
Publicado: (2017)

Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors
por: Syenina, Ayesa, et al.
Publicado: (2015)

Corrigendum: Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
por: Ha, Ji-Hee, et al.
Publicado: (2017)

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies
por: Skegro, Darko, et al.
Publicado: (2017)

Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response
por: Sartorius, Rossella, et al.
Publicado: (2018)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Altered Fc galactosylation in IgG(4) is a potential serum marker for chronic lung disease
por: Heyder, Tina, et al.
Publicado: (2018)

Parameter Identification for a Model of Neonatal Fc Receptor-Mediated Recycling of Endogenous Immunoglobulin G in Humans
por: Kendrick, Felicity, et al.
Publicado: (2019)

mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
por: Buhre, Jana Sophia, et al.
Publicado: (2023)

Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions
por: Lopez, Ester, et al.
Publicado: (2019)

Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
por: Liu, Yun, et al.
Publicado: (2023)

Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis
por: Nabeshima, Yuka, et al.
Publicado: (2021)

Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin
por: Lion, Julien, et al.
Publicado: (2017)

A Retrospective Observational Study of Adverse Reactions Associated With Intravenous Immunoglobulin Infusion
por: Kato, Hidefumi, et al.
Publicado: (2021)

Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors
por: Jones, Richard J., et al.
Publicado: (2020)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
por: Liu, Xiaosheng, et al.
Publicado: (2020)

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
por: Dekkers, Gillian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ghgc2rofdc4un44jrpkrp2spp